SLC22A17 and Alzheimer disease: In AD patients, LCN2-positive reactive astroglia increase in correlation with the prevalence of neuritic plaques (Fig. 6), suggesting that NGFR/LCN2/SLC22A17 signaling axis could be a critical fate determination step between neurogenic versus reactive gliotic response in disease.